Correction: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis (Health Economics Review, (2023), 13, 1, (1), 10.1186/s13561-022-00411-w)

Hesam Ghiasvand; Shiva Khaleghparast; Naser Kachoueian; Kourosh Tirgarfakheri; Meysam Mortazian; Yaser Toloueitabar; Farhad Gorjipour; Seyran Naghdi

ArticleOPEN ACCESS

Correction: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis (Health Economics Review, (2023), 13, 1, (1), 10.1186/s13561-022-00411-w)

Health Economics Review

DOI: 10.1186/s13561-023-00420-3

0Citations

2Readers

Abstract

Following publication of the original article [1], the authors would like to correct the statement in Ethics approval and consent to participate section for the reason that the ethics code issuer is a Center that is affiliated with the Iran University of Medical Sciences, and not the University itself. The statement currently reads: This study has been approved by the Ethics Research Committee of Iran University of Medical Sciences.

Cite

CITATION STYLE

APA

Ghiasvand, H., Khaleghparast, S., Kachoueian, N., Tirgarfakheri, K., Mortazian, M., Toloueitabar, Y., … Naghdi, S. (2023, December 1). Correction: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis (Health Economics Review, (2023), 13, 1, (1), 10.1186/s13561-022-00411-w). Health Economics Review. BioMed Central Ltd. https://doi.org/10.1186/s13561-023-00420-3

Correction: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis (Health Economics Review, (2023), 13, 1, (1), 10.1186/s13561-022-00411-w)

Abstract

Cite

Register to see more suggestions